Equities

bluebird bio Inc

bluebird bio Inc

Actions
  • Price (USD)0.4127
  • Today's Change0.036 / 9.67%
  • Shares traded14.56k
  • 1 Year change-87.45%
  • Beta--
Data delayed at least 20 minutes, as of Nov 08 2024 18:24 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments222180300
Total Receivables, Net------
Total Inventory2300
Prepaid expenses158.6226
Other current assets, total221511
Total current assets282204337
Property, plant & equipment, net267299101
Goodwill, net5.655.655.65
Intangibles, net104.870
Long term investments01.4197
Note receivable - long term------
Other long term assets11127.78
Total assets619570594
LIABILITIES
Accounts payable181526
Accrued expenses8981124
Notes payable/short-term debt000
Current portion long-term debt/capital leases8561--
Other current liabilities, total8.1203.43
Total current liabilities200157153
Total long term debt38700
Total debt1221300
Deferred income tax------
Minority interest------
Other liabilities, total18720967
Total liabilities425435220
SHAREHOLDERS EQUITY
Common stock1.910.830.71
Additional paid-in capital4,4554,1864,096
Retained earnings (accumulated deficit)(4260)(4048)(3720)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(1.8)(4.07)(2.91)
Total equity195134374
Total liabilities & shareholders' equity619570594
Total common shares outstanding1938371
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.